retatrutide investigational drug weight loss A New Obesity Delivered Surgery-Level in Clinical Trials Retatrutide: New Obesity Drug and

Public Health Service Policy on Humane Care and Use of Laboratory Animals and the Guide for the Care and Use of Laboratory Animals (National Research Council, 8th edition, 2011)

Initial treatments may require several injections per week, followed by maintenance doses every month

Continuous infusion is administered through a modified insulin pump, most commonly dispensing in a 12-16 h regimen, although it can be given throughout the 24 h and need not be discontinued at night

Delaney G, Jacob S, Featherstone C, Barton M

We are committed to providing our patients with the most advanced and effective options for managing type 2 diabetes and obesity